Plain-English translation of NCT03097952 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study — meaning researchers will follow and learn from people who already have chronic hepatitis B infection, rather than testing a new medication. The study will collect information about your medical history, symptoms, blood tests, and other health factors to build a detailed database. This information will help doctors better understand which patients are at higher risk for serious complications like cirrhosis or liver cancer.
Doctors know that chronic hepatitis B can lead to serious liver disease, but they don't fully understand which patients will develop complications and which ones will do well over time. This study aims to identify the specific factors — like viral levels, immune response, and lifestyle factors — that predict outcomes, so doctors can better predict and prevent these complications in the future.
You likely qualify if…
You likely don't qualify if…
You will be enrolled in a long-term observation study where researchers will regularly collect information about your health, including medical records, blood test results, and details about any symptoms or treatments you receive. There is no experimental medication to take — instead, you'll be monitored over time so researchers can track how your hepatitis B progresses and identify patterns that predict outcomes. The study is recruiting 20,000 patients in the Jiangsu region of China.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China